Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis
Research output: Contribution to journal › Article › peer-review
Standard Standard
Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis. / Ridyard, Colin; Blair, Jo ; Hughes, Dyfrig.
In: Value in Health, Vol. 20, No. 9, 20.10.2017, p. A582.
In: Value in Health, Vol. 20, No. 9, 20.10.2017, p. A582.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Ridyard, C, Blair, J & Hughes, D 2017, 'Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis', Value in Health, vol. 20, no. 9, pp. A582. https://doi.org/10.1016/j.jval.2017.08.1042
APA
Ridyard, C., Blair, J., & Hughes, D. (2017). Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis. Value in Health, 20(9), A582. https://doi.org/10.1016/j.jval.2017.08.1042
CBE
Ridyard C, Blair J, Hughes D. 2017. Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis. Value in Health. 20(9):A582. https://doi.org/10.1016/j.jval.2017.08.1042
MLA
Ridyard, Colin, Jo Blair, and Dyfrig Hughes. "Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis". Value in Health. 2017, 20(9). A582. https://doi.org/10.1016/j.jval.2017.08.1042
VancouverVancouver
Ridyard C, Blair J, Hughes D. Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis. Value in Health. 2017 Oct 20;20(9):A582. doi: 10.1016/j.jval.2017.08.1042
Author
RIS
TY - JOUR
T1 - Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis
AU - Ridyard, Colin
AU - Blair, Jo
AU - Hughes, Dyfrig
PY - 2017/10/20
Y1 - 2017/10/20
U2 - 10.1016/j.jval.2017.08.1042
DO - 10.1016/j.jval.2017.08.1042
M3 - Article
VL - 20
SP - A582
JO - Value in Health
JF - Value in Health
SN - 1098-3015
IS - 9
T2 - ISPOR 20th Annual European Congress
Y2 - 4 November 2017 through 8 November 2017
ER -